SWOG clinical trial number
S0336

Phase II Trial of Depsipeptide (NSC-630176) in Colorectal Cancer Patients Who Have Received Either One or Two Chemotherapy Regimens for Metastatic or Locally Advanced, Unresectable Disease

70% Accrual
Accrual
70%
Closed
Phase
70% Accrual
Accrual
70%
Published
Abbreviated Title
COLORECTAL
Activated
04/15/2004
Closed
09/01/2005
Participants
NCORP, Members, Medical Oncologists

Research committees

Gastrointestinal Cancer

Treatment

Depsipeptide